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Abstract
Background: Female reproductive potential, or the ability to propagate life, is limited in mammals with the
majority of oocytes lost before birth. In mice, surviving perinatal oocytes are enclosed in ovarian follicles for
subsequent oocyte development and function in the adult. Before birth, fetal germ cells of both sexes develop in
clusters, or germline cysts, in the undifferentiated gonad. Upon sex determination of the fetal gonad, germ cell
cysts become organized into testicular or ovarian cord-like structures and begin to interact with gonadal somatic
cells. Although germline cysts and testicular cords are required for spermatogenesis, the role of cyst and ovarian
cord formation in mammalian oocyte development and female fertility has not been determined.
Results: Here, we examine whether intact fetal ovarian germ and somatic cell cord structures are required for
oocyte development using mouse gonad re-aggregation and transplantation to disrupt gonadal organization. We
observed that germ cells from disrupted female gonad prior to embryonic day e13.5 completed prophase I of
meiosis but did not survive following transplantation. Furthermore, re-aggregated ovaries from e13.5 to e15.5
developed with a reduced number of oocytes. Oocyte loss occurred before follicle formation and was associated
with an absence of ovarian cord structure and ovary disorganization. However, disrupted ovaries from e16.5 or later
were resistant to the re-aggregation impairment and supported robust oocyte survival and development in
follicles.
Conclusions: Thus, we demonstrate a critical window of oocyte development from e13.5 to e16.5 in the intact
fetal mouse ovary, corresponding to the establishment of ovarian cord structure, which promotes oocyte
interaction with neighboring ovarian somatic granulosa cells before birth and imparts oocytes with competence to
survive and develop in follicles. Because germline cyst and ovarian cord structures are conserved in the human
fetal ovary, the identification of genetic components and molecular mechanisms of pre-follicle stage germ and
somatic cell structures may be important for understanding human female infertility. In addition, this work provides
a foundation for development of a robust fetal ovarian niche and transplantation based system to direct stem cell-
derived oocyte differentiation as a potential therapeutic strategy for the treatment of infertility.
Background
Ovarian follicles, consisting of an oocyte and surround-
ing somatic granulosa cells, are essential for oocyte
survival and maturation [1,2]; however, the role of pre-
follicle stage fetal ovarian germ and somatic cell struc-
tures in directing mammalian oocyte development has
not been well defined. Prior to follicle formation, germ
cell precursors of several species have been observed to
develop in cysts [3,4]. Germline cyst formation occurs
by incomplete cytokinesis during mitosis, resulting in
the connection of daughter cells by intercellular bridges.
In Drosophila, cyst formation and intercellular bridge-
mediated transport of organelles and RNA determine
oocyte fate and fertility of the adult female [5-7].
Mouse primordial germ cells (PGCs) also develop in
cyst-like clusters following colonization of the genital
ridge and subsequent cell division. The maximum num-
ber of germ cell clusters is detected on embryonic day
e13.5 just prior to commitment, or maturation, of PGCs
to an oocyte developmental program and successive
entry into meiosis [8]. Upon commitment, oocyte clus-
ters become organized into poorly defined ovarian, or
ovigerous, cord-like structures containing oocytes and
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ian cords and cysts break down into follicles character-
ized by oocyte apoptosis, the organization of granulosa
cells around surviving oocytes, and basement membrane
remodeling [9-11]. Follicle formation therefore appears
to require intricate synchronization of oocyte precursor
germ cells and pre-granulosa somatic cells [12,13].
Although ovarian cyst and cord break down has been
implicated in follicle formation [10], it is not yet known
whether cyst and/or cord formation is required for
mammalian oocyte development before follicle forma-
tion. Previously, intercellular bridges were found to be
dispensable for female fertility in mammals [14]; how-
ever, germ cell cyst formation was not obstructed in
mice lacking bridges, and, therefore, the requirement of
cyst and cord formation for oocyte development could
not be determined. Here, we use fetal ovary re-aggrega-
tion and transplantation to directly perturb ovarian cysts
and cords, and we demonstrate that intact ovarian cord
formation and maturation promote oocyte survival and
development.
Results
Intact ovary maturation promotes oocyte development
To investigate the role of intact ovarian cords in pro-
moting oocyte development, we dissected fetal to new-
born stage mouse female genital ridges and ovaries,
dissociated the tissues to single cells, re-aggregated the
dissociated cells, and then transplanted the re-aggre-
gated tissues under the kidney capsules of bilaterally
ovariectomized immuno-deficient mouse recipients for
three weeks. Post-transplantation, we constructed a
timeline denoting the competence of gonads at different
stages of development to support oocyte survival and
maturation. For this purpose, transplanted grafts from
e11.5 to post-natal P2 female gonadal stages were sec-
tioned and analyzed for the presence of oocyte-contain-
ing follicles by hematoxylin and eosin staining following
re-aggregation and transplantation as described [15].
Follicles containing oocytes with visible nuclei were
counted on every 10
th section, and the average follicle
number per graft (n = 3 grafts per gonadal stage) was
normalized either per section or per weight (mg) of
graft tissue. No significant difference was found between
normalization methods (per weight normalization not
shown).
We observed that the number of oocytes in follicles
detected following re-aggregation and transplantation was
not equal and generally increased with the age of embryos
used as ovary donors (Figures 1A and 2A). Oocytes that
were not enclosed in follicles were never detected by
VASA immunostaining analysis of any ovarian stage fol-
lowing three weeks of transplantation (data not shown).
In contrast to significant folliculogenesis following
transplantation of intact gonadal controls (Figure 1B) or
endogenous adult ovary in vivo controls (Figure 1C), ovar-
ian follicles were not detected from re-aggregated e11.5 or
e12.5 female genital ridges (Figures 1A and 2A). Rare
oocytes in follicles were observed beginning from re-
aggregated e13.5 ovaries, and follicle number increased
from e13.5 to e16.5, with a significant elevation from e15.5
to e16.5 (Figure 2A). Robust folliculogenesis was sup-
ported by re-aggregated e16.5 to P2 ovarian stages.
E11.5 to e14.5 transplants were then sectioned
through and examined in their entirety to ensure that
the absence of follicles observed before e13.5 could not
be due to dilution of oocytes by ovarian somatic cells
that had greater proliferative potential at these earlier
gonadal stages. We confirmed an absence of follicles
from e11.5 and e12.5 transplants and detected similarly
low numbers of oocytes from e13.5 and e14.5 samples
(data not shown). In fact, the average weight of grafts
was nearly identical between e11-12.5 and e17.5-P2
gonadal stage transplants (Figure 2B). Furthermore, the
re-aggregation impairment of oocyte development from
early ovarian stages was not a non-specific effect of phy-
sical gonadal disruption but rather a biological function
of gonadal stage prior to the disruption, as oocyte devel-
opment occurred following re-aggregation and trans-
plantation of later stage ovaries that were treated
identically. To rule out the possibility of later stage
ovary resistance to enzymatic dissociation to single cells
as being responsible for robust oocyte development,
newborn ovaries were dissociated as described, then fil-
tered through a 40 μm membrane to remove cell clumps,
a n dF A C Ss o r t e df o rs i n g l ec e l l sb a s e do nf o r w a r da n d
side scatter parameters to exclude doublets and to ensure
a single cell suspension before re-aggregation. Indeed,
FACS sorted and re-aggregated newborn ovaries still sup-
ported robust oocyte development of equivalent numbers
of follicles after transplantation (36 follicles/section for
P2 and P2 FACS samples) (Figure 1D). Thus, the results
of the re-aggregation time course indicated that
pre-e13.5 stage gonadal cells were not yet competent to
support oocyte development following disruption. We
concluded that intact ovarian development on e13.5 was
important for oocyte survival and maturation in follicles.
Intact ovaries are not required for oocyte meiotic entry
or progression
Re-aggregated female germ cells became competent to
develop as oocytes in follicles after e13.5 and corre-
sponded to the time of female sex determination and PGC
commitment to an oocyte developmental program on
e13.5 in vivo [16]. Soon after their commitment, oocytes
begin to enter meiotic prophase I from e13.5 to e16.5
[17,18], representing an early hallmark of fetal oocyte
development and also paralleling the increase in oocyte
development observed in our re-aggregation timeline.
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Page 2 of 13Figure 1 Female gonadal re-aggregation prior to ovary maturation impaired oocyte development. (A) Female mouse genital ridges and
ovaries from e11.5 (embryonic day) to P2 (post-natal day) were disrupted by re-aggregation, transplanted under the kidney capsule for three
weeks, and sections were examined by H&E stain for oocyte development in follicles in comparison to intact (B) gonadal transplant controls.
(C) For comparison, in vivo control endogenous time points are shown to illustrate e12.5 genital ridge, pre-follicle formation e14.5 differentiating
ovary, and post-follicle formation adult ovary. (D) P2 ovaries were also FACS sorted prior to re-aggregation to ensure a single cell suspension and
an equivalent dissociation method. 100× magnification.
Figure 2 Quantification of re-aggregation induced impairment of oocyte development. (A) The average number of oocytes in follicles per
graft, normalized to the number of sections counted, was determined following three weeks transplantation of intact or re-aggregated samples.
No oocytes were detected in re-aggregated samples prior to e13.5. Oocyte numbers increased in re-aggregated samples after e13.5 in parallel to
the increasing age of ovary donors, however, oocyte numbers were still significantly reduced from e13.5 to e15.5 compared to intact control
samples. (B) Average weight per graft following transplantation of re-aggregated early and late gonadal stages demonstrating equivalent
weights. Error bars represent s.d. (n = 3, 150 sections/graft). * = p < 0.05 between e16.5 and e15.5 re-aggregated. **/*** = p < 0.05 between
e12.5/e14.5 intact and re-aggregated, respectively.
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Page 3 of 13Consequently, we examined pre-e13.5 stage germ cells
for meiotic entry and progression as a measure of
oocyte commitment, and we observed that re-aggregated
germ cells were still competent to commit to an oocyte
developmental program and enter meiosis following
transplantation (Figure 3A). Re-aggregated or intact
e12.5 female genital ridges transplanted for three days
and assayed by immunofluorescence for expression and
localization of synaptonemal complex protein markers
of meiotic chromosome synapsis displayed an almost
equivalent percentage of meiotic cells. Both samples
contained oocytes that expressed markers of zygotene to
diplotene stages of meiotic prophase such as chromoso-
mal alignment of SYCP3 (SYnaptonemal Complex Pro-
tein 3; 59% in intact and 51% in re-aggregated), and
markers of pachytene to diplotene stages such as chro-
mosomal localization of SYCP1 (45% in intact and 33%
in re-aggregated) (Figure 3B). Thus, the complete
absence of oocytes and follicles from re-aggregated
e12.5 samples was not due to lack of oocyte commit-
ment and entry into meiosis.
To determine the extent of meiotic progression, we
examined e12.5 genital ridges after five days of transplan-
tation and detected only a small percentage of cells that
stained positive for chromosomal elongated localization
of SYCP3 and SYCP1 for either re-aggregated or intact
control samples (6% in intact and 14% in re-aggregated
for SYCP3; 4% in intact and 2% in re-aggregated for
SYCP1) (data not shown). These results indicated
that germ cells from both intact and re-aggregated e12.5
Figure 3 Genital ridge re-aggregation did not affect oocyte meiotic entry or progression but disrupted oocyte survival and
development in follicles. (A) Intact or re-aggregated (re-agg) e12.5 female genital ridges were transplanted for three days, and germ cells were
subsequently analyzed for entry and progression through stages of meiosis prophase I by SYCP3 and SYCP1 immunostaining of chromosome
synapsis. Blue is DAPI. 630× magnification. (B) Intact or re-aggregated e12.5 samples on day three of transplantation were quantified for the
percentage of cells in meiotic prophase I as determined by SYCP chromosomal alignment localization by immunofluorescence. Error bars
represent s.d. (n = 3, 100 cells/graft). No statistically significant difference was detected. (C) By 12 days of transplantation, many primordial and
primary follicles were observed from the intact e12.5 genital ridge but none were detected from the re-aggregated genital ridge by H&E stain.
200× magnification.
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phase I to dictyate arrest as oocytes and subsequently
down-regulated the expression of SYCP proteins. Down-
regulation of SYCP1 upon successful meiotic progression
of oocytes has been suggested to facilitate follicle forma-
tion [19]. Therefore, PGC commitment to oogenesis and
oocyte progression through meiotic prophase I did not
appear to be affected by re-aggregation, although we can-
not eliminate the possibility of defects in DNA mismatch
or double strand break repair. In addition, neither com-
plete sex reversal to spermatogenesis and testicular struc-
tures nor ectopic PGC reprogramming and teratoma
formation following genital ridge disruption were ever
observed.
Intact ovary maturation supports oocyte survival before
follicle formation
Although germ cells entered and progressed through
early stages of meiosis as committed oocytes in the
three to five day transplants from re-aggregated e12.5
female genital ridge, the oocytes did not survive at three
weeks of transplantation. We hypothesized that re-
aggregation either directly impaired oocyte survival or
impaired the development of ovarian somatic cells and
indirectly led to oocyte degeneration subsequent to an
obstruction in the formation of follicles. Thus, intact
and re-aggregated e12.5 genital ridges were examined
along a time course of transplantation to determine
when oocyte loss occurred with respect to follicle for-
mation and ovarian somatic granulosa cell development,
and to elucidate a germ cell or somatic cell basis for the
re-aggregation impairment of oocyte survival.
Endogenous ovarian follicle formation occurs just after
birth in mice. As expected, follicles were not detected
from either intact or re-aggregated e12.5 samples after
only five to seven days of transplantation, comparable to
e17.5 to e19.5 pre-natal stages; however, many primordial
follicles were identified from the intact e12.5 female geni-
tal ridge beginning on day 12 of transplantation. In con-
trast, ovarian follicles were not observed from the
re-aggregated e12.5 genital ridge on day 12 (Figure 3C).
To further characterize oocyte loss, we investigated the
decline in oocyte number by TRA98 oocyte marker
immunostaining of intact and re-aggregated e12.5 female
genital ridges after transplantation for five, seven, and 12
days. Intact control transplants exhibited gradual oocyte
loss during the time course, similar to oocyte loss in vivo,
with 20% of oocytes from day five of transplantation sur-
viving to day 12 and forming follicles. Previously, endo-
genous peri-natal oocyte loss in vivo was reported to
occur through programmed ovarian germ cell cyst break
down, with 33% of oocytes surviving to form primordial
follicles [10,20]. In contrast, re-aggregation resulted in
accelerated oocyte loss and significant reduction in
oocyte number by day seven of transplantation with no
oocytes surviving to day 12 (Figure 4A). Thus, oocytes
from re-aggregated genital ridge were being lost by day
seven of transplantation before follicle formation on day
12 and suggested an oocyte-specific impairment as a
cause rather than a consequence of folliculogenesis
obstruction. Furthermore, FOXL2+ ovarian somatic
granulosa cells survived and were detected at all time
points of re-aggregated transplantation in similar num-
bers to intact samples despi t et h ea b s e n c eo fT R A 9 8 +
oocytes, in line with prior observations [21,22], confirm-
ing a re-aggregation induced oocyte-specific deficiency
(Figure 4C).
To determine the mechanism of oocyte loss after re-
aggregation, we examined markers of apoptosis follow-
ing transplantation of intact or re-aggregated e12.5
female genital ridge and detected evidence of Caspase-
independent apoptosis. Although activated Caspase2 and
3 apoptotic pathways have been previously implicated in
oocyte death [23-29], TRA98+ oocytes expressing active
Caspase2 or Caspase3 were not detected following re-
aggregation. However, 2% of oocytes expressed active
Caspase2 in intact genital ridge, and active Caspase3
was observed in some FOXL2+ granulosa cells from
both samples (Figure 4B, C). In contrast, we detected no
TRA98/TUNEL double positive apoptotic oocytes in the
intact samples after five days of transplantation, while
1.7% of the TRA98+ oocytes were TUNEL+ in the re-
aggregated genital ridge (Figure 4B, B’). On day seven,
we detected 2% and 2.7% TUNEL+ apoptotic oocytes
in intact and re-aggregated samples, respectively
(Figure 4B, B’’). Therefore, a small increase in TUNEL+
apoptotic oocytes was observed following re-aggregation
indicating that TUNEL+, Caspase-independent apoptosis
may play a role in re-aggregation induced oocyte loss.
However, other mechanisms of cell death or loss, such
as necrosis and/or autophagy, are likely to be involved
in oocyte reduction/depletion as well. Additionally,
oocyte differentiation can not be excluded.
Intact ovarian cord formation promotes oocyte survival
and development
Having demonstrated that oocytes are directly impaired
and lost before follicle formation following disruption of
the e12.5 female genital ridge, we next explored the
properties of the ovary that develop on e13.5 and enable
oocyte survival after re-aggregation and transplantation.
We observed that re-aggregation resulted in the disorga-
nization of ovary structure and corresponded to the
absence of ovarian cord formation and subsequent
oocyte loss. In transplants of intact e12.5 female genital
ridge, TRA98+ oocytes and FOXL2+ granulosa cells co-
localized to large clusters or ovarian cords by five days
of transplantation that correlated with successive oocyte
survival and follicle formation on day 12. However,
ovarian cords were significantly disrupted in transplants
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Page 5 of 13from re-aggregated e12.5 female genital ridge, as clusters
of TRA98+ oocytes and FOXL2+ granulosa cells were
n o to b s e r v e da ta n yt i m ep o i n ta f t e rt r a n s p l a n t a t i o n
(Figure 4C). Instead, individual TRA98+ oocytes were
distributed evenly throughout the re-aggregated gonad
after five to seven days of transplantation and were not
detected by day 12 (Figures 4C and 5).
In contrast, FOXL2+ granulosa cells were found to re-
organize in clusters following re-aggregation, however,
these granulosa cell domains were not specifically
enriched for oocytes and exhibited a distinctly different
morphology from intact ovarian follicles. In contrast to
FOXL2+ granulosa cells throughout the somatic cell
layers of intact ovarian follicles and adjacent to the
oocyte, FOXL2+ cells were confined to the perimeter of
these re-aggregated clusters with several layers of
FOXL2-, DAPI+ cells at the interior facing an oocyte-
less lumen (Figure 4C’,C ’’). Oocytes were occasionally
observed in a FOXL2+ cluster, but this non-specific
interaction was the result of random oocyte distribution
and dense granulosa cell domains after disruption and
re-aggregation (Figure 5). Thus, the survival and
Figure 4 Re-aggregation obstructed intact ovarian cord structure and induced Caspase-independent oocyte loss before follicle
formation. (A) The numbers of surviving oocytes per graft were determined by TRA98 immunofluorescence following five, seven, and 12 days
of intact or re-aggregated (re-agg) e12.5 female genital ridge transplantation revealing oocyte loss by d7 before follicle formation on d12. Error
bars represent s.d. (n = 3) */** = p < 0.05 between d7/d12 re-aggregated and intact, respectively. (B) Re-aggregation induced oocyte loss was
Caspase-independent. The percentage of TRA98+ oocytes (100 cells/graft) undergoing apoptosis was assayed by TUNEL and active Caspase2 or
Caspase3 co-immunofluorescence following five to seven days of transplantation. Intact = solid bars. Re-aggregated = striped bars. TUNEL+ (red)
apoptotic oocytes co-stained for TRA98 (green) were detected in re-aggregated samples following 5 (B') and 7 (B'') days of transplantation
(C) Ovarian cord structure was examined by TRA98 germ cell and FOXL2 granulosa somatic cell immunofluorescence over 12 days of e12.5
female genital ridge transplantation. Oocytes and granulosa cells clustered together in defined ovarian cord-like structures (dashed lines)
following five to seven days of intact sample transplantation, and ovarian follicles were detected by day twelve. Re-aggregated samples did not
form ovarian cords or follicles during the time course, and TRA98+ oocytes were not detected after day seven in re-aggregated transplants.
Active Caspase3 was not detected in oocytes. (C' and C'') Clusters containing FOXL2+ cells were observed following re-aggregation, however,
FOXL2+ cells were only detected at the perimeter of these clusters, and neither FOXL2+ nor TRA98+ cells were ever observed at the interior in
contrast to intact ovarian follicles. C' and C'' panels: DAPI - blue, FOXL2 - red, and TRA98 - green. 100× magnification.
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Page 6 of 13re-organization of granulosa cells, and oocyte lack
thereof, was indicative of an oocyte-specific deficiency
induced by re-aggregation that corresponded to disrup-
tion of ovarian cord formation.
Re-aggregation also resulted in ovary disorganization
of other somatic cell types that correlated with ovarian
cord disruption and oocyte loss. In intact e12.5 female
genital ridge transplants, somatic cells expressing
PECAM (Figure 6A) and Laminin (Figure 6B), markers
of endothelial cells and basement membrane, respec-
tively, were predominantly separated from oocytes by
intact ovarian cords. Of note, we did not detect PECAM
expression in oocytes following five days of e12.5 genital
ridge transplantation (equivalent to e17.5), confirming a
prior report that PECAM expression is extinguished in
oocytes by e16 and, thus, can be used as a somatic cell-
specific marker at this stage [30]. In re-aggregated sam-
ples, in contrast, somatic cells expressing PECAM and
Laminin were instead uniformly interspersed, along with
randomly dispersed oocytes and granulosa cell clusters,
by day five of transplantation (Figure 6A, B). Therefore,
in addition to disruption of ovarian cords, disorganized
somatic cell contact- and/or paracrine signaling-
mediated oocyte toxicity induced by the re-aggregation
could also play a role in the lack of oocyte survival.
To distinguish ovarian cord disruption from somatic
cell toxicity mechanisms of re-aggregation-induced
oocyte loss, e12.5 female genital ridges were again disso-
ciated to obstruct ovarian cord formation. Instead of re-
aggregation, germ cells were purified from e12.5 somatic
cells, which may be inhibitory, and were then co-aggre-
gated with later stage e16.5 and P2 ovaries. Notably, we
previously found disrupted and re-aggregated e16.5 and
P2 ovarian stages capable of supporting robust oocyte
survival and development as characterized by ovarian
somatic cell organization and folliculogenesis (Figures
1A and 2A). Therefore, the inability of e12.5 germ cells
to survive as oocytes and contribute to follicle formation
and development with later stage ovarian somatic cells
would reflect an oocyte-specific deficiency. As such, we
used a transgenic Oct4-GFP mouse model [31] to purify
e12.5 germ cells from the female genital ridge by fluor-
escence activated cell sorting (FACS). Purified GFP+
e12.5 germ cells were then directly co-aggregated with
e16.5 and P2 ovarian tissues and transplanted for three
weeks. Following transplantation, however, we could not
identify any GFP+ germ cell-derived oocytes (data not
shown) indicating a lack of germ cell-specific compe-
tency at the e12.5 stage to support oocyte survival and
development.
Figure 5 Re-aggregation impaired intact ovarian cord formation. Low magnification (40×) analysis of ovary structure by TRA98 germ cell
and FOXL2 granulosa somatic cell immunofluorescence after five days of e12.5 female genital ridge transplantation revealed the striking
difference in ovary organization between intact and re-aggregated samples. Intact sample oocytes and granulosa cells clustered together in
defined ovarian cord-like structures (dashed lines), in contrast to re-aggregated samples which did not form ovarian cords containing oocyte
clusters. Active Caspase3 was not detected in oocytes.
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impairment, we next sought to rule out e12.5-derived
oocyte loss due to unsynchronized germ and somatic
cell stages. Previous studies suggested that pre-natal
oocyte development requires synchronization of germ
and somatic cells [12,13], in contrast to post-natal stages
where synchronization is not required [32]. Accordingly,
e12.5 Oct4-GFP+ germ cells were isolated by FACS and
synchronized with later stage ovarian somatic cells by
in vitro c u l t u r ef o rt h r e ed a y st oi n d u c eo o c y t ee n t r y
into and progression through meiosis that corresponded
to an e15-17.5 stage of ovary development. GFP+ germ
cells were cultured on cell culture inserts in media sup-
plemented with several factors adapted from a prior
report of in vitro PGC survival and entry into meiosis in
the absence of somatic cells [33]. Purified germ cells
were alkaline phosphatase positive and continued to
express GFP in vitro, confirming their germ cell identity
(Figure 7). Furthermore, 78% of germ cells had entered
meiosis by day three of culture as determined by SYCP3
and SYCP1 expression and elongated chromosomal
localization, indicating a zygotene to pachytene stage of
meiosis prophase I and confirming oocyte maturation
in vitro. Meiotic oocytes were subsequently co-aggre-
gated with permissive e16.5 or P2 ovaries and trans-
planted. However, we were still unable to detect e12.5
germ cell-derived GFP+ oocyte survival and develop-
ment even though many GFP- oocytes from e16.5 and
P2 ovaries were observed in follicles (Figure 7). Thus,
we confirmed a re-aggregation-induced, e12.5-derived
deficiency that was oocyte-intrinsic and corresponded to
a disruption of intact ovarian cord formation, demon-
strating a critical window from e13.5 to e16.5 of oocyte
development in the intact ovary for subsequent oocyte
survival and maturation in follicles.
Furthermore, preliminary results have been obtained
to further confirm an oocyte-specific impairment by
performing a reverse experiment. Ovarian tissue from
permissive e16.5 embryos was co-aggregated with
somatic mesonephros tissue from non-permissive e13.5
ovaries and transplanted for 12 days. Oocytes from
e16.5 ovaries have already been exposed to intact ovar-
ian cord structures beginning at e13.5 of development.
Based on our previous results suggesting oocyte survival
following re-aggregation to be an oocyte-intrinsic func-
tion of intact ovarian cord development from e13.5 to
e16.5, we expected that these e16.5 oocytes would be
competent to survive and form follicles, even when in
the presence of somatic tissue from the genital ridges of
pre-competent stages. Indeed, e16.5 oocytes survived to
form follicles and further suggested an oocyte-intrinsic
impairment following the disruption of intact ovarian
cord structure during early genital ridge and ovarian
stages (data not shown). Nevertheless, we do not
exclude the possibility that re-aggregated somatic cells
from the early female genital ridge and ovary contribute
Figure 6 Oocyte loss was associated with ovary disorganization following re-aggregation. (A, B) Immunofluorescence revealed TRA98+
oocytes and FOXL2+ granulosa cells in ovarian cord-like structures (dashed lines) primarily sequestered from PECAM+ endothelial cells (A) and
Laminin+ basment membrane (B) following five days of intact e12.5 female genital ridge transplantation. Along with disrupted ovarian cord
formation, re-aggregation also resulted in a uniform distribution of PECAM+ and Laminin+ cells amongst dispersed oocytes and granulosa cells
that correlated with subsequent oocyte loss. 100× magnification.
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along with the absence of intact ovarian cords.
Discussion
In the present study, we demonstrate that intact ovarian
cord formation promotes oocyte development. The
female embryonic genital ridge was not competent to
support oocyte survival when disrupted prior to e13.5
ovary maturation and cord formation. Furthermore,
oocyte competence to survive and develop in follicles
following ovary re-aggregation paralleled the duration of
oocyte development within intact fetal ovarian cords
from e13.5 to e16.5 prior to their disruption. Pre-ovarian
genital ridge re-aggregation did not affect germ cell sex
determination or commitment to oogenesis and entry
into meiosis (Table 1). However, pre-ovarian e12.5
re-aggregation triggered oocyte loss before follicle for-
mation, which was independent of Caspase pathway
activation, and was correlated with obstruction of ovar-
ian cord formation and ovary disorganization. In con-
trast, granulosa cells survived re-aggregation and
exhibited re-organization, indicating an oocyte-specific
deficiency. Moreover, heterochronic experiments of pre-
ovarian stage germ cell co-aggregation with later stage
ovary somatic cells, that were competent to direct folli-
cle formation following re-aggregation, did not support
e12.5-derived oocyte survival and confirmed a critical
role for e13.5-e16.5 intact ovarian structures in pro-
gramming oocytes with intrinsic competence to survive
and develop in follicles.
Based on our results, we suggest a model in which
intact ovarian cord structures that develop on e13.5 pro-
vide factors that support oocyte development (Figure 8).
A notable aspect of intact ovary maturation is the devel-
opment of oocytes in clusters which may facilitate cell
contact and/or paracrine signal support of oocyte survi-
val. In a previous study, intercellular bridges were not
required for oocyte cyst formation and female fertility,
although their absence resulted in significant peri-natal
oocyte loss [14]. However, germ cell contacts have also
been reported to occur by cadherin protein adhesion
in vivo and in vitro as early as the PGC migratory stage
Figure 7 Disruption of intact ovarian structure by re-aggregation resulted in oocyte loss due to an oocyte-specific deficiency.T o
distinguish between oocyte-specific or somatic cell-specific mechanisms of re-aggregation-induced oocyte loss, germ cells from e12.5 female
genital ridges of Oct4-GFP transgenic mice were purified from somatic cells by FACS, and GFP+ and alkaline phosphatase (AP+) germ cells were
cultured in vitro for three days to induce meiosis (SYCP3+) and to synchronize germ cells with later ovarian stages. Subsequently, cultured GFP+
germ cells were co-aggregated with permissive e16.5 or P2 stage ovarian tissue and transplanted for three weeks. In contrast to Oct4-GFP
transgenic ovary controls with robust oocyte-specific GFP expression, e12.5-derived GFP+ oocytes were not detected after transplantation and
indicated a re-aggregation induced oocyte-specific impairment following pre-ovarian genital ridge disruption.
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vival in the absence of intercellular bridge support
[34-36]. Although re-aggregation-mediated disruption of
intercellular bridges may have contributed to the reduc-
tion in oocyte numbers following transplantation, we
attribute the complete absence of oocyte survival to the
additional perturbation of ovarian cyst and cord struc-
tures. Furthermore, ovarian cords are comprised of
pre-granulosa somatic cells, and pre-granulosa-oocyte
interactions through cell contacts and/or paracrine fac-
tors may promote oocyte survival as well [37]. Cord
organization of granulosa cells in close physical proxi-
mity to oocytes may also facilitate cyst break down and
follicle formation [10,11,22], and the results presented
here support this notion. Our results are also in agree-
ment with a previous report of in vitro follicle formation
Table 1 Summary of analysis and results following e12.5 female genital ridge transplantation.
Days of
Transplantation
Analysis
a Re-Agg Gonad Intact Gonad In Vivo
b Control
3 Meiosis Zygotene-pachytene of
meiosis I
Zygotene-pachytene of meiosis I Zygotene-pachytene of meiosis I [18]
5 Ovarian Cord
Formation
Ovarian cords do not form
and ovary disorganized
Ovarian cords form with distinct
organization of oocyte and
granulosa cell clusters
Ovarian cords form with distinct
organization of oocyte and granulosa
cell clusters [1]
7 Oocyte Survival Oocyte numbers significantly
reduced compared to
intact gonad
Oocyte numbers reduced compared
to day 5
Oocyte numbers decline due to
programmed breakdown [10]
12-21 Oocyte Development
in Follicles
Oocytes do not survive to
day 12 and follicles not
observed
Oocytes survive, form follicles, and
mature
Oocytes survive, form follicles, and
mature [2]
a For all experiments, n = 3 transplants with 4 embryos or 8 gonads per transplant
b In vivo control refers to e15.5, e17.5, e19.5, and P4 - P14 stages
Figure 8 Model of intact ovarian cord formation and maturation promoting oocyte survival and development in follicles. Prior to ovary
development on e13.5, germ cells located in cysts in the e12.5 female genital ridge are not yet competent to survive and form follicles when re-
aggregated (re-agg). However, ovary maturation on e13.5 and development of intact ovarian cord structures containing oocyte and somatic
granulosa cell clusters are sufficient to permit some oocyte survival and follicle formation upon re-aggregation. By e16.5, intact ovarian cord-
enclosed meiotic oocyte clusters and granulosa somatic cells are now primed to undergo robust follicle formation and oocyte development in
follicles when re-aggregated. The percentage of surviving re-aggregated oocytes was calculated in comparison to intact transplant controls.
Oocyte (green) and granulosa cell (blue) contacts and paracrine signaling factors may promote oocyte survival (+) and possibly facilitate
programmed ovarian germ cell cyst break down into follicles. The cord and/or oocyte-mediated recruitment of granulosa cell clusters during
ovary differentiation may also provide somatic cell signaling factors such as WNT4, R-spondin1, and Follistatin that promote oocyte survival and
maturation. In addition, intact ovarian cords may facilitate the protection of oocytes from re-aggregation induced inhibitory signaling from
somatic cells in the genital ridge. Thus, we define a critical window from e13.5 to e16.5 of oocyte enclosure in intact fetal ovarian cord structures
for the intrinsic programming of oocytes with competence to survive and undergo further development.
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Page 10 of 13from e13.5 ovaries but not from e12.5 genital ridge, con-
firming an important role for ovarian cord structures
that develop in the intact ovary [12].
While disruption of the genital ridge resulted in an
oocyte-intrinsic impairment that was independent of
somatic granulosa cells, the possibility exists that other
types of somatic cells in the re-aggregated genital ridge
contributed to oocyte loss. Somatic endothelial and
basement membrane cell types expressing PECAM and
laminin were inappropriately localized in close proximity
to oocytes following re-aggregation. Therefore, in addi-
tion to directly imparting oocytes with competence to
survive and form follicles, intact ovarian cords that
d e v e l o po ne 1 3 . 5m a yb er e q u i r e dt oh e l pp r o t e c t
oocytes from deleterious factors expressed by somatic
cells in the gonad and/or mesonephros, ensuring oocyte
survival and development (Figure 8). Although the
mesonephros has traditionally been referenced as a facil-
itator of female ovary maturation and oocyte meiosis
[38-40], the mesonephros also contributes to testicular
cord formation and development [41,42]. In addition to
the presence of meiotic oocytes [43], WNT4, R-spon-
din1, and Follistatin somatic cell signaling factors were
required for ovary sex determination and repressed tes-
ticular endothelial and somatic cell migration from the
mesonephros [44-48]. Female mice containing genetic
null mutations in these factors developed disorganized
ovaries with oocytes that entered meiosis but did not
survive; analogous to the phenotype reported in this
study. The unexplained oocyte loss in these mutant
mice therefore may be an indirect consequence of ovary
disorganization downstream of the mutation. In the cur-
rent study, although ovarian somatic cell signaling path-
ways were not mutated, genital ridge disruption was
sufficient to prevent re-organization of ovary structure
and potential ovarian cord protection of oocytes from
restrictive factors. Future studies will determine genital
ridge somatic cell contribution to oocyte loss following
re-aggregation and disruption of the ovarian cords.
Conclusions
In conclusion, we report that intact ovarian cord struc-
tures that develop on e13.5 are critical for oocyte devel-
opment. Thus, we emphasize the significance of intact
ovary organization during mid (e13.5) to late (e16.5)
gestation for programming oocytes with intrinsic com-
petence to survive and later develop in mouse ovarian
follicles after birth. Human oocytes also develop in cyst-
and cord-like structures [49], and identification of
genetic mutations and/or environmental toxins affecting
human fetal ovary organization could provide insight
into lack of human oocyte survival and development in
premature ovarian failure-based cases of infertility.
Additionally, the understanding of intact fetal ovarian
structure and function will facilitate the development of
a robust transplantation-based ovarian niche to direct
the maturation of oocytes from other potential sources,
such as embryonic stem cells, for the treatment of
female infertility.
Methods
Gonad re-aggregation and kidney capsule transplantation
The transplantation system was adapted from a previous
report of successful oocyte maturation following new-
born ovary re-aggregation and transplantation under the
kidney capsule [50]. Fetal to newborn stage female
gonads with the mesonephros were dissected from wild
type CD-1 mice (Charles River) and dissociated to single
cell suspensions by a 10 minute 0.25% trypsinization fol-
lowed by pipetting 10-20 times and re-suspension in
standard media (DMEM, 10% FBS, 1% L-glutamine;
Invitrogen). For e11.5 to e13.5 stages, genomic DNA
was isolated from somatic tissue of each embryo and
genotyped for Sry to confirm the gender (Zymo) [51].
The gonadal cell suspension from 4 embryos or pups
was then mixed with 0.2 mg/mL of phytohemagglutinin
(Sigma). Cell suspensions were pelleted at 10,000 × g for
1 minute, and pellets were incubated overnight in stan-
dard media on CM cell culture inserts (Millipore) at
37°C. Pellets, or grafts, were transplanted under the kid-
ney capsule of bi-laterally ovariectomized CB.17 SCID
recipient mice (Charles River) according to the protocol
(#16146) approved by the Stanford University Adminis-
trative Panel on Laboratory Animal Care and as
described in detail on the NIH Biology of Mammary
Gland website link: http://mammary.nih.gov/tools/mou-
sework/Cunha001/Pages/Written_Method.html.
Meiotic cell spread and immunofluorescence
Following transplantation, tissues were dissociated as
above and re-suspended in 20 μL of hypo-extraction
buffer pH-8.2 (30 mM Tris pH 8.2, 50 mM Sucrose,
17 mM Citric Acid, 5 mM EDTA, 0.5 mM DTT, and
1% protease inhibitor cocktail (all Sigma)) for 30 min-
utes at room temperature. 60 μLo f1 0 0m MS u c r o s e
was then added, and the cell suspension was spread
onto slides pre-coated with 1% Paraformaldehyde (USB
Corporation) and 0.15% Triton-X100 (Sigma) in PBS
pH-9.2, and dried overnight at room temperature. Slides
were blocked in 4% chicken serum (Abcam) and incu-
bated overnight at 4â—¦C with primary antibody in
TBST (tris buffered saline (TBS), 1% BSA, and 0.1%
Tween-20 (all Sigma)) and 1% serum. Primary antibodies
included rabbit anti-SYCP3 (1:1000, Abcam, ab15092)
and rabbit anti-SYCP1 (1:500, Abcam, ab15090). Slides
were subsequently incubated with Alexa Fluor chicken
anti-rabbit (1:1000, Invitrogen) secondary antibodies for
30 minutes, and cover slips were mounted with Prolong
Gold Antifade with DAPI (Invitrogen).
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Grafts were fixed overnight in 4% Paraformaldehyde
(USB Corporation), embedded in paraffin, and sectioned
in 5 to 8 μm intervals. In brief, sections on slides were
de-paraffinized, re-hydrated, antigens unmasked by incu-
bating in Target Retrieval Solution (Dako) at 95â—¦C
for 30 minutes, permeabilized in 0.1% Triton-X100
(Sigma) for 5 minutes, blocked with 10% chicken serum
in TBST overnight, and incubated with primary anti-
body in TBST with 1% serum for 1 hour at room tem-
perature. Primary antibodies included anti-VASA rabbit
polyclonal (1:500, Abcam, ab13840), anti-TRA98 rat
monoclonal (1:500, B-Bridge, 73-003) [52,53], anti-
FOXL2 goat polyclonal (1:100, Abcam, ab5096), active
anti-Caspase2 (ab2251) or anti-Caspase3 (ab13847) rab-
bit polyclonal (both 1:100, Abcam), anti-CD31 PECAM
rabbit polyclonal (1:20, Abcam, ab28364), anti-Laminin
rabbit polyclonal (1:200, Abcam, ab11575), and anti-GFP
rabbit monoclonal E385 (1:1000, Abcam, ab32146).
After washing in TBST, slides were incubated with sec-
ondary antibody for 30 minutes at room temperature.
Secondary antibodies included Alexa Fluor chicken anti-
rabbit, rat, and goat (1:1000, Invitrogen), and cover slips
were mounted with Prolong Gold Antifade with DAPI
(Invitrogen). The terminal deoxynucleotidyl transferase
dUTP nick end labeling (TUNEL) assay was performed
prior to co-immunofluorescence according to the manu-
facturer’s instructions (Roche Diagnostics).
Fluorescence activated cell sorting (FACS)
Oct4-GFP gonads were dissociated to single cells with
0.25% Trypsin (Invitrogen) for 5-10 minutes at 37°C and
re-suspended in standard media. Cells were strained
through a 40 μm filter (BD Biosciences) and then ana-
lyzed on a BD-FACSAria cell sorting system (BD Bios-
ciences). Post sorting, 10 to 20 thousand GFP+ germ
cells were re-plated per well on a 24-well PET 0.4 μm
cell culture insert (BD Falcon) for three days in standard
media supplemented with a germ cell factor cocktail
adapted from [33]: mouse SCF 100 ng/mL, mouse SDF1
20 ng/mL, mouse bFGF 20 ng/mL, mouse BMP4 50 ng/
mL (all R&D Systems), N-acetylcysteine 1 mg/mL, For-
skolin 5 μM, Retinoic Acid 1 μM (all Sigma), and
CYP26 inhibitor R115866 1 μM (Johnson&Johnson).
The GFP+ germ cells were then trypsinized and co-
aggregated with dissociated wild type e16.5 or P2 ovar-
ian tissue and transplanted as described above.
Statistical analysis
Data are represented as mean +/- standard deviation (s.d.).
Statistical significance was determined by unpaired Stu-
dent’s t-Test of unequal variance. Following transplanta-
tion, grafts from at least three separate transplants per
fetal/newborn stage were sectioned and sampled by count-
ing oocytes with nuclei in follicles on every tenth section
for 150 sections by H&E stain. Follicle number per graft
was normalized per section or normalized per milligram
(mg) of graft tissue. For meiotic entry and progression, 100
cells from each of three separate transplants per sample
were analyzed for meiotic chromosome synapsis. For
oocyte survival, the numbers of TRA98+ oocytes were
counted in three separate samples per time point. For
apoptotic markers, at least 100 TRA98+ oocytes were
assessed for co-expression of active Caspase2/3 or TUNEL.
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